Revenue of the Generative Artificial Intelligence (AI) In Drug Discovery Market Predicted to Achieve $0.86 Billion by 2030, Driven by 27% CAGR
Uncover key drivers, emerging technologies, and competitive movements shaping the generative artificial intelligence (ai) in drug discovery market from 2026–2035 with trusted insights from The Business Research Company
What is the estimated market size of the Generative Artificial Intelligence (AI) In Drug Discovery Market by the end of 2030?
The market size for generative artificial intelligence (AI) in drug discovery has seen substantial growth recently. It is forecast to increase from $0.25 billion in 2025 to $0.33 billion in 2026, achieving a compound annual growth rate (CAGR) of 30.6%. Historically, this expansion has been driven by factors such as the high costs involved in drug development, developments in computational chemistry, the increasing availability of biological datasets, the adoption of machine learning tools, and investment in pharmaceutical R&D.
The generative artificial intelligence (AI) in drug discovery market size is anticipated to experience substantial growth over the next few years. It is projected to expand to $0.86 billion by 2030, achieving a compound annual growth rate (CAGR) of 27.0%. This expansion during the forecast period can be primarily linked to the incorporation of generative models into development pipelines, the escalating demand for expedited drug discovery, the broader application of biologics optimization, strategic alliances between AI and pharmaceutical companies, and the reduction in time required to bring products to market. Significant developments anticipated during this timeframe encompass the increasing implementation of AI-driven molecule generation, a greater reliance on deep learning in designing drugs, the wider adoption of small molecule discovery applications, the growing integration of AI in lead optimization, and a faster pace in early-stage drug development.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16067&type=smp
What Drivers Are Shaping Future Opportunities In The Generative Artificial Intelligence (AI) In Drug Discovery Market?
The increasing volume of clinical trials is anticipated to drive the expansion of generative AI within the drug discovery market. These trials utilize human participants to evaluate the safety and efficacy of novel medical interventions or processes, with the goal of collecting scientific evidence regarding their applicability for human consumption. This growth in clinical trials stems mainly from progress in medical research, a greater prevalence of diseases, evolving regulations, the worldwide expansion of clinical studies, stronger patient advocacy and public awareness, competitive industry pressures, technological innovations, and improved funding avenues. Data from clinical trials powers generative AI models, accelerating drug discovery through the prediction of molecular interactions and the design of new compounds. This collaborative effort facilitates personalized medical approaches, enhances the effectiveness of treatments, leads to better patient results, and fundamentally transforms the pharmaceutical sector. As an illustration, in January 2025, Pharmaceutical Technology, a UK-based business news and media firm, reported that 3,213 trials are scheduled to commence this year, comprising 823 in Phase I and 1,102 in Phase II. Similar to 2024, oncology is projected to maintain its position as the leading therapeutic area, with 946 trials, followed by the central nervous system with 686 trials, and then cardiovascular significantly trailing with 258 trials. Consequently, the increased volume of clinical trials is propelling the expansion of generative AI in the drug discovery market.
Which Segments Are Gaining Traction In The Generative Artificial Intelligence (AI) In Drug Discovery Market?
The generative artificial intelligence (AI) in drug discovery market covered in this report is segmented –
1) By Type: Small Molecule, Large Molecule
2) By Technology: Deep Learning, Machine Learning, Reinforcement Learning, Molecular Docking, Quantum Computing
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutions, Contract Research Organizations (CROs), Other End-Users
Subsegments:
1) By Small Molecule: Drug Design And Optimization, Lead Discovery And Identification, Toxicology Prediction, Molecular Property Prediction, ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Prediction
2) By Large Molecule: Protein Structure Prediction, Antibody Design, Biologics Optimization, Peptide Design, Biopharmaceutical Discovery And Optimization
What Trends Are Driving The Growth Trajectory Of The Generative Artificial Intelligence (AI) In Drug Discovery Market?
Leading companies in the generative AI drug discovery market are actively developing sophisticated AI-powered tools to accelerate the drug discovery process. These AI-driven instruments speed up drug development by streamlining discovery, design, and clinical trials through the application of predictive analytics and machine learning. They enhance efficiency in areas such as target identification, compound screening, including virtual screening using AI, as well as preclinical development, regulatory compliance, and manufacturing processes. As an illustration, in May 2023, Google Cloud, a US-based cloud computing service provided by Google, introduced two innovative AI-driven solutions. These solutions, the Target and Lead Identification Suite and the Multiomics Suite, are designed to advance drug discovery and precision medicine across biotech, pharmaceutical, and public sector organizations. The Target and Lead Identification Suite assists researchers in understanding amino acid functions and predicting protein structures, while the Multiomics Suite expedites the analysis and understanding of genomic data, simplifying the development of personalized treatments.
Who Are The Core Companies Influencing Trends In The Generative Artificial Intelligence (AI) In Drug Discovery Market?
Major companies operating in the generative artificial intelligence (AI) in drug discovery market are Bayer AG, NVIDIA Corporation, Merck KGaA, IBM Research, Schrödinger Inc., Valo Health, BenevolentAI, XtalPi Inc., Insilico Medicine Inc., Recursion Pharmaceuticals Inc., Exscientia, Atomwise Inc., InveniAI LLC, Healx, Aitia, Cloud Pharmaceuticals Inc., Optibrium, Aiforia, BioSymetrics Inc., Collaborations Pharmaceuticals Inc., MAbSilico, Reverie Labs, Standigm Inc., DeepMatter Group Limited, Variational AI Inc
Access The Complete Report For Deeper Market Insights:
Which Region Is Expected To Experience The Fastest Growth In The Generative Artificial Intelligence (AI) In Drug Discovery Market?
North America was the largest region in the generative AI in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative artificial intelligence (AI) in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Generative Artificial Intelligence (AI) In Drug Discovery Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=16067&type=smp
Browse Through More Reports Similar to the Global Generative Artificial Intelligence (AI) In Drug Discovery Market 2026, By The Business Research Company
Lab Automation In Drug Discovery Market Report 2026
Artificial Intelligence In Drug Discovery Market Report 2026
Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
